NCT01082393

Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: University Hospital, Ghent · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

We will investigate the process of vitiligo induction and the influence of different commonly used cream treatments on this process. Studies comparing different treatments for vitiligo in the induction stage of the disease are still missing. The study hypothesis = cream treatment can stop actively spreading vitiligo lesions during the early induction stage of the disease.

Conditions

• Vitiligo

Interventions

Type	Name	Description
DRUG	topical tacrolimus treatment	4 applications (day 1,day 3, day 6 and day10)
DRUG	topical pimecrolimus treatment	4 applications (day 1, day 3, day 6 and day 10)
DRUG	local mometasone furoate treatment	4 applications (day 1, day 3, day 6 and day 10)
DRUG	cold cream	4 applications (day 1, day 3, day 6 and day 10)

Timeline

• Start date: 2010-02-16
• Primary completion: 2015-09-15
• Completion: 2015-12-01
• First posted: 2010-03-08
• Last updated: 2022-12-08

Locations

1 site across 1 country: Belgium